GoKawiilStudy finds WEE1 kinase blocks APC/C-CDH1 to drive cell cycle entry into S phase
Researchers used synchronized human cell lines, including hTert-RPE1, MCF7 and KU1919, arrested via contact inhibition or the CDK4/6 inhibitor palbociclib, to study cell cycle regulation. Their experiments indicate that WEE1 kinase activity counteracts the APC/C-CDH1 complex, a ubiquitin ligase that normally restrains cell cycle progression, thereby enabling cells to transition into S phase.
GoKawiil's interpretation of the reporting above, not reported fact.
Understanding how WEE1 interacts with APC/C-CDH1 could clarify fundamental mechanisms controlling when cells replicate DNA, which is relevant to cancer biology since both WEE1 and APC/C pathways are frequently dysregulated in tumors. This could inform future research into WEE1 inhibitors, which are already being explored as cancer therapeutics, by revealing additional roles these drugs might disrupt in cell cycle control.
- WEE1 kinase appears to inhibit APC/C-CDH1 activity to allow cells to enter S phase
- The study used multiple synchronization methods (contact inhibition, palbociclib) across several human cell lines
- Findings could have implications for understanding WEE1 inhibitors used in cancer treatment
Source: nature.com — Vuillemenot, 2026-10-21
Published there as: “WEE1 opposes APC/C<sup>CDH1</sup> activity to promote S phase entry”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.